Venmax Drugs & Pharmaceuticals standalone net profit rises 300.00% in the June 2025 quarter
Sales rise 1110.00% to Rs 1.21 crore
Net profit of Venmax Drugs & Pharmaceuticals rose 300.00% to Rs 0.04 crore in the quarter ended June 2025 as against Rs 0.01 crore during the previous quarter ended June 2024. Sales rose 1110.00% to Rs 1.21 crore in the quarter ended June 2025 as against Rs 0.10 crore during the previous quarter ended June 2024. ParticularsQuarter EndedJun. 2025Jun. 2024% Var.Sales1.210.10 1110 OPM %3.31-20.00 -PBDT0.040.01 300 PBT0.040.01 300 NP0.040.01 300Powered by Capital Market - Live News
Disclaimer: No Business Standard Journalist was involved in creation of this content